#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14448	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2075	691.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	798	C,G	750,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14448	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2075	691.2	0	HET	.	.	.	C451T	.	451	451	C	683	683	C	803	C,T	564,192	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27336	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3560	764.9	0	.	n	.	0	T695C	SNP	695	695	T	1119	1119	C	838	C	782	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27336	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3560	764.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2395	2395	C	868	C	788	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27336	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3560	764.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2469	2469	A	868	A	810	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27336	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3560	764.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3021	3021	C	851	C,A	794,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27336	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3560	764.9	0	HET	.	.	.	G452A	.	452	452	G	876	876	G	836	G,A	586,177	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1872	folP	855	855	100.0	folP.l15.c17.ctg.1	1608	116.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1059	1061	AGC	184;183;184	A;G;C,G	171;170;170,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5134	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3547	144.4	1	SNP	p	S91F	1	.	.	271	273	TTC	570	572	TTC	188;192;193	T;T;C	176;179;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5134	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3547	144.4	1	SNP	p	D95G	1	.	.	283	285	GGC	582	584	GGC	180;181;180	G;G;C	169;171;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5134	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3547	144.4	1	SNP	p	G95N	0	.	.	283	285	GGC	582	584	GGC	180;181;180	G;G;C	169;171;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1546	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1342	114.7	1	SNP	p	G45D	0	.	.	133	135	GGC	459	461	GGC	179;177;176	G;G;C	168;166;164	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	742	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	913	80.5	0	.	n	.	0	A197.	DEL	197	197	A	482	482	A	157	A	149	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	200.1	1	SNP	p	D86N	0	.	.	256	258	GAC	570	572	GAC	249;249;252	G;A;C	230;222;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	200.1	1	SNP	p	S87R	1	.	.	259	261	CGT	573	575	CGT	253;254;252	C;G;T	235;234;230	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	200.1	1	SNP	p	R87W	0	.	.	259	261	CGT	573	575	CGT	253;254;252	C;G;T	235;234;230	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	200.1	1	SNP	p	R87I	0	.	.	259	261	CGT	573	575	CGT	253;254;252	C;G;T	235;234;230	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5808	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	200.1	1	SNP	p	S88P	0	.	.	262	264	TCC	576	578	TCC	252;257;254	T;C;C	231;239;240	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4114	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2594	157.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1460	1462	GGC	187;183;182	G;G;C	174;169;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1246	1248	GCC	232;233;233	G;C;C	209;212;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1249	1251	ATG	233;233;236	A;T;G	212;211;216	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1261	1263	ACC	231;233;234	A;C;C	207;213;215	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1261	1263	ACC	231;233;234	A;C;C	207;213;215	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1762	1764	ACC	203;205;205	A;C;C,T	183;187;187,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1816	1818	GCG	228;226;226	G;C;G	212;205;212	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1816	1818	GCG	228;226;226	G;C;G	212;205;212	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1939	1941	GGT	193;191;193	G;G;T	177;174;172	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1948	1950	AGC	175;174;173	A;G;C	158;159;157	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4090	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	167.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1966	1968	CCG	157;158;162	C,CG;C;G	102,1;111;115	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5566	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3027	183.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	228;225;223	C;C;G	201;204;193	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2428	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1717	140.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	564	564	C	159	C	142	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2776	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1600	172.7	0	.	p	.	0	G48E	NONSYN	142	144	GGA	433	435	GAA	236;233;232	G;A;A	216;213;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2776	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1600	172.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	940	942	GGT	224;227;229	G;G;T,C	211;216;215,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2776	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1600	172.7	1	SNP	p	G120K	1	.	.	358	360	AAG	649	651	AAG	210;211;213	A;A;G	195;195;195	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2776	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1600	172.7	1	SNP	p	N121D	0	.	.	361	363	AAC	652	654	AAC	214;214;217	A;A;C	201;200;201	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2776	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1600	172.7	1	SNP	p	A121N	1	.	.	361	363	AAC	652	654	AAC	214;214;217	A;A;C	201;200;201	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10462	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4923	212.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1030	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1033	98.9	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	223;222;215	A;T;G	205;204;197	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
